Detalles de la búsqueda
1.
Persistence, Adherence, and Switching to Higher-Cost Therapy in Patients with Multiple Sclerosis Initiating Oral Disease-Modifying Therapies: A Retrospective Real-World Study.
Neurol Ther
; 11(4): 1735-1748, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36152222
2.
Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in The Danish Multiple Sclerosis Registry.
PLoS One
; 16(5): e0250820, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34003862
Resultados
1 -
2
de 2
1
Próxima >
>>